4//SEC Filing
SALIX PHARMACEUTICALS LTD 4
Accession 0001209191-14-011870
CIK 0001009356operating
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 5:03 PM ET
Size
10.1 KB
Accession
0001209191-14-011870
Insider Transaction Report
Form 4
LOGAN CAROLYN J
DirectorPresident & CEO
Transactions
- Gift
Common Stock
2014-02-06−400,000→ 501,405.2 total - Gift
Common Stock
2014-02-06+400,000→ 400,000 total(indirect: By GRAT)
Holdings
- 33,750
Option to Buy Common Stock
Exercise: $18.87Exp: 2014-06-17→ Common Stock (33,750 underlying) - 65,625
Option to Buy Common Stock
Exercise: $18.87Exp: 2014-06-17→ Common Stock (65,625 underlying) - 44,000
Option to Buy Common Stock
Exercise: $17.63Exp: 2015-06-09→ Common Stock (44,000 underlying)
Footnotes (1)
- [F1]Options are 100% vested.
Documents
Issuer
SALIX PHARMACEUTICALS LTD
CIK 0001009356
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001009356
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 5:03 PM ET
- Size
- 10.1 KB